Facebook Pixel

New Antiarrhythmic Drugs for Atrial Fibrillation -- Dronedarone (Multaq) and Vernakalant, – Video

Rate This

At the Boston Atrial Fibrillation Symposium 2010, Professor John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.

See the video: Interview with Professor John Camm at Boston Atrial Fibrillation Symposium 2010

Mellanie True Hills Bio

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Atrial Fibrillation

Get Email Updates

Atrial Fibrillation Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!